1. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Jr., Colvin MM, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America. Circul. 2017;136(6):e137-e61.
2. Pecini R, Moller DV, Torp-Pedersen C, Hassager C, Kober L. Heart failure etiology impacts survival of patients with heart failure. Int J Cardiol. 2011;149(2):211-5.
3. Tyminska A, Ozieranski K, Balsam P, Maciejewski C, Wancerz A, Brociek E, et al. Ischemic cardiomyopathy versus non-ischemic dilated cardiomyopathy in patients with reduced ejection fraction- clinical characteristics and prognosis depending on heart failure etiology (data from European Society of Cardiology Heart Failure Registries). Biol (Basel). 2022;11(2):341.
4. Singh P, Bhatt B, Pawar SU, Kamra A, Shetye S, Ghorpade M. Role of myocardial perfusion study in differentiating ischemic versus nonischemic cardiomyopathy using quantitative parameters. Indian J Nucl Med. 2018;33(1):32-8.
5. Edalat-Javid M, Shiri I, Hajianfar G, Abdollahi H, Arabi H, Oveisi N, et al. Cardiac SPECT radiomic features repeatability and reproducibility: a multi-scanner phantom study. J Nucl Cardiol. 2021;28(6):2730-44.